CSIMarket


Supernus Pharmaceuticals inc   (SUPN)
Other Ticker:  
 

Supernus Pharmaceuticals inc

SUPN's Fundamental analysis








Looking into Supernus Pharmaceuticals Inc growth rates, revenue grew by 5.2 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1886

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.79 %

Supernus Pharmaceuticals Inc 's net income grew by 943.45 % in IV. Quarter 2022 year on year, above company average,

More on SUPN's Growth


Supernus Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Supernus Pharmaceuticals Inc realized cash outflow of $ -1.89per share in trailing twelve-month period.
Company
37.02
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 3.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.


More on SUPN's Valuation
 
 Total Debt (Millions $) 402
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.22
 Tangible Book Value (Per Share $) 1.14

Supernus Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Supernus Pharmaceuticals Inc realized cash outflow of $ -1.89per share in trailing twelve-month period.
Company
37.02
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 3.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.

Supernus Pharmaceuticals Inc Price to Book Ratio is at 2.36 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

More on SUPN's Valuation

  Market Capitalization (Millions $) 2,088
  Shares Outstanding (Millions) 58
  Employees -
  Revenues (TTM) (Millions $) 667
  Net Income (TTM) (Millions $) 61
  Cash Flow (TTM) (Millions $) -110
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 402
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.22
  Tangible Book Value (Per Share $) 1.14

  Market Capitalization (Millions $) 2,088
  Shares Outstanding (Millions) 58
  Employees -
  Revenues (TTM) (Millions $) 667
  Net Income (TTM) (Millions $) 61
  Cash Flow (TTM) (Millions $) -110
  Capital Exp. (TTM) (Millions $) -


    SUPN's Profitability Comparisons
Supernus Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in IV. Quarter 2022 to 20.52 %.

Supernus Pharmaceuticals Inc net profit margin of 15.23 % is currently ranking no. 36 in Major Pharmaceutical Preparations industry, ranking no. 78 in Healthcare sector and number 938 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.37
  Total Debt to Equity (MRQ) 0.45
  Tangible Leverage Ratio (MRQ) 9.96
  Asset Turnover Ratio (TTM) 0.38
  Inventory Turnover Ratio (TTM) 1



Supernus Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in IV. Quarter 2022 to 20.52 %.

Supernus Pharmaceuticals Inc net profit margin of 15.23 % is currently ranking no. 36 in Major Pharmaceutical Preparations industry, ranking no. 78 in Healthcare sector and number 938 in S&P 500.

More on SUPN's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RLMD's Profile

Stock Price

RLMD's Financials

Business Description

Fundamentals

Charts & Quotes

RLMD's News

Suppliers

RLMD's Competitors

Customers & Markets

Economic Indicators

RLMD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071